Nitric oxide in skeletal muscle: Role on mitochondrial biogenesis and function

International Journal of Molecular Sciences

Volumn 13, Issue 12, 2012, Pages 17160-17184

  Tengan, Celia Harumi ^a   Rodrigues, Gabriela Silva ^a   Godinho, Rosely Oliveira ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Mitochondria; Mitochondrial biogenesis; Mitochondrial disease; Nitric oxide; Nitric oxide synthase

Indexed keywords

ACONITATE HYDRATASE; ARGININE; ATORVASTATIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME B; CYTOCHROME C OXIDASE; DEFLAZACORT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLURBIPROFEN 4 NITROXYBUTYL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL DNA; MOLSIDOMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RESVERATROL; SIMVASTATIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ABSENCE OF SIDE EFFECTS; BIOGENESIS; DUCHENNE MUSCULAR DYSTROPHY; ELECTRON TRANSPORT; EXERCISE; HUMAN; MELAS SYNDROME; MITOCHONDRIAL RESPIRATION; MUSCLE DEVELOPMENT; MUSCLE MITOCHONDRION; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOPATHY; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY CHAIN; REVIEW; RHABDOMYOLYSIS; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; METABOLISM; MITOCHONDRIAL DYNAMICS; PHYSIOLOGY;

ANIMALS; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL TURNOVER; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTORS;

EID: 84871671895     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131217160     Document Type: Review

References (156)

1. Cohn, J.N.; McInnes, G.T.; Shepherd, A.M. Direct-acting vasodilators. J. Clin. Hypertens. 2011, 13, 690-692.
2. Ghafourifar, P.; Cadenas, E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 2005, 26, 190-195.
3. Boveris, A.; Costa, L.E.; Poderoso, J.J.; Carreras, M.C.; Cadenas, E. Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann. N. Y. Acad. Sci. 2000, 899, 121-135.
4. Nisoli, E.; Clementi, E.; Paolucci, C.; Cozzi, V.; Tonello, C.; Sciorati, C.; Bracale, R.; Valerio, A.; Francolini, M.; Moncada, S.; et al. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science 2003, 299, 896-899.
5. Lira, V.A.; Brown, D.L.; Lira, A.K.; Kavazis, A.N.; Soltow, Q.A.; Zeanah, E.H.; Criswell, D.S. Nitric oxide and ampk cooperatively regulate pgc-1 in skeletal muscle cells. J. Physiol. 2010, 588, 3551-3566.
6. Toledo, J.C., Jr.; Augusto, O. Connecting the chemical and biological properties of nitric oxide. Chem. Res. Toxicol. 2012, 25, 975-989.
7. Dudzinski, D.M.; Igarashi, J.; Greif, D.; Michel, T. The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 235-276.
8. Nathan, C.; Xie, Q.W. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994, 78, 915-918.
9. Stamler, J.S.; Meissner, G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81, 209-237.
10. Stuehr, D.J. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 1997, 37, 339-359.
11. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: Structure, function and inhibition. Biochem. J. 2001, 357, 593-615.
12. Bredt, D.S.; Snyder, S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 1990, 87, 682-685.
13. Eissa, N.T.; Yuan, J.W.; Haggerty, C.M.; Choo, E.K.; Palmer, C.D.; Moss, J. Cloning and characterization of human inducible nitric oxide synthase splice variants: A domain, encoded by exons 8 and 9, is critical for dimerization. Proc. Natl. Acad. Sci. USA 1998, 95, 7625-7630.
14. Forstermann, U.; Boissel, J.P.; Kleinert, H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (nos i and nos iii). FASEB J. 1998, 12, 773-790.
15. Eliasson, M.J.; Blackshaw, S.; Schell, M.J.; Snyder, S.H. Neuronal nitric oxide synthase alternatively spliced forms: Prominent functional localizations in the brain. Proc. Natl. Acad. Sci. USA 1997, 94, 3396-3401.
16. Brenman, J.E.; Chao, D.S.; Gee, S.H.; McGee, A.W.; Craven, S.E.; Santillano, D.R.; Wu, Z.; Huang, F.; Xia, H.; Peters, M.F.; et al. Interaction of nitric oxide synthase with the postsynaptic density protein psd-95 and alpha1-syntrophin mediated by pdz domains. Cell 1996, 84, 757-767.
17. Larsson, B.; Phillips, S.C. Isolation and characterization of a novel, human neuronal nitric oxide synthase cdna. Biochem. Biophys. Res. Commun. 1998, 251, 898-902.
18. Wang, Y.; Goligorsky, M.S.; Lin, M.; Wilcox, J.N.; Marsden, P.A. A novel, testis-specific mrna transcript encoding an nh2-terminal truncated nitric-oxide synthase. J. Biol. Chem. 1997, 272, 11392-11401.
19. Marsden, P.A.; Schappert, K.T.; Chen, H.S.; Flowers, M.; Sundell, C.L.; Wilcox, J.N.; Lamas, S.; Michel, T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992, 307, 287-293.
20. Miyahara, K.; Kawamoto, T.; Sase, K.; Yui, Y.; Toda, K.; Yang, L.X.; Hattori, R.; Aoyama, T.; Yamamoto, Y.; Doi, Y.; et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 1994, 223, 719-726.
21. Lorenz, M.; Hewing, B.; Hui, J.; Zepp, A.; Baumann, G.; Bindereif, A.; Stangl, V.; Stangl, K. Alternative splicing in intron 13 of the human enos gene: A potential mechanism for regulating enos activity. FASEB J. 2007, 21, 1556-1564.
22. Chartrain, N.A.; Geller, D.A.; Koty, P.P.; Sitrin, N.F.; Nussler, A.K.; Hoffman, E.P.; Billiar, T.R.; Hutchinson, N.I.; Mudgett, J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1994, 269, 6765-6772.
23. Zweier, J.L.; Samouilov, A.; Kuppusamy, P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1999, 1411, 250-262.
24. Kobzik, L.; Stringer, B.; Balligand, J.L.; Reid, M.B.; Stamler, J.S. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships. Biochem. Biophys. Res. Commun. 1995, 211, 375-381.
25. Bates, T.E.; Loesch, A.; Burnstock, G.; Clark, J.B. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem. Biophys. Res. Commun. 1995, 213, 896-900.
26. Ohkoshi, N.; Mizusawa, H.; Fujita, T.; Shoji, S. Histological determination of nitric oxide synthase (nos) and nadph-diaphorase in ragged-red fibers from patients with mitochondrial encephalomyopathies. J. Neurol. Sci. 1997, 149, 151-156.
27. Tengan, C.H.; Kiyomoto, B.H.; Godinho, R.O.; Gamba, J.; Neves, A.C.; Schmidt, B.; Oliveira, A.S.; Gabbai, A.A. The role of nitric oxide in muscle fibers with oxidative phosphorylation defects. Biochem. Biophys. Res. Commun. 2007, 359, 771-777.
28. Giulivi, C.; Poderoso, J.J.; Boveris, A. Production of nitric oxide by mitochondria. J. Biol. Chem. 1998, 273, 11038-11043.
29. Ghafourifar, P.; Richter, C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 1997, 418, 291-296.
30. Lacza, Z.; Puskar, M.; Figueroa, J.P.; Zhang, J.; Rajapakse, N.; Busija, D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic. Biol. Med. 2001, 31, 1609-1615.
31. Lacza, Z.; Snipes, J.A.; Zhang, J.; Horvath, E.M.; Figueroa, J.P.; Szabo, C.; Busija, D.W. Mitochondrial nitric oxide synthase is not enos, nnos or inos. Free Radic. Biol. Med. 2003, 35, 1217-1228.
32. Tatoyan, A.; Giulivi, C. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria. J. Biol. Chem. 1998, 273, 11044-11048.
33. Carreras, M.C.; Peralta, J.G.; Converso, D.P.; Finocchietto, P.V.; Rebagliati, I.; Zaninovich, A.A.; Poderoso, J.J. Modulation of liver mitochondrial nos is implicated in thyroid-dependent regulation of o(2) uptake. Am. J. Physiol. Heart Circ. Physiol. 2001, 281, H2282-H2288.
34. Lopez-Figueroa, M.O.; Caamano, C.; Morano, M.I.; Ronn, L.C.; Akil, H.; Watson, S.J. Direct evidence of nitric oxide presence within mitochondria. Biochem. Biophys. Res. Commun. 2000, 272, 129-133.
35. French, S.; Giulivi, C.; Balaban, R.S. Nitric oxide synthase in porcine heart mitochondria: Evidence for low physiological activity. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H2863-H2867.
36. Vinas, J.L.; Sola, A.; Hotter, G. Mitochondrial nos upregulation during renal i/r causes apoptosis in a peroxynitrite-dependent manner. Kidney Int. 2006, 69, 1403-1409.
37. Xu, C.; Yi, C.; Wang, H.; Bruce, I.C.; Xia, Q. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening. Shock 2012, 37, 110-115.
38. Venkatakrishnan, P.; Nakayasu, E.S.; Almeida, I.C.; Miller, R.T. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J. Biol. Chem. 2009, 284, 19843-19855.
39. Tay, Y.M.; Lim, K.S.; Sheu, F.S.; Jenner, A.; Whiteman, M.; Wong, K.P.; Halliwell, B. Do mitochondria make nitric oxide? No? Free Radic. Res. 2004, 38, 591-599.
40. Bates, T.E.; Loesch, A.; Burnstock, G.; Clark, J.B. Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation? Biochem. Biophys. Res. Commun. 1996, 218, 40-44.
41. Marks, J.D.; Boriboun, C.; Wang, J. Mitochondrial nitric oxide mediates decreased vulnerability of hippocampal neurons from immature animals to nmda. J. Neurosci. 2005, 25, 6561-6575.
42. Bustamante, J.; Czerniczyniec, A.; Cymeryng, C.; Lores-Arnaiz, S. Age related changes from youth to adulthood in rat brain cortex: Nitric oxide synthase and mitochondrial respiratory function. Neurochem. Res. 2008, 33, 1216-1223.
43. Haynes, V.; Elfering, S.; Traaseth, N.; Giulivi, C. Mitochondrial nitric-oxide synthase: Enzyme expression, characterization, and regulation. J. Bioenerget. Biomembr. 2004, 36, 341-346.
44. Kanai, A.J.; Pearce, L.L.; Clemens, P.R.; Birder, L.A.; VanBibber, M.M.; Choi, S.Y.; de Groat, W.C.; Peterson, J. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc. Natl. Acad. Sci. USA 2001, 98, 14126-14131.
45. Lacza, Z.; Horn, T.F.; Snipes, J.A.; Zhang, J.; Roychowdhury, S.; Horvath, E.M.; Figueroa, J.P.; Kollai, M.; Szabo, C.; Busija, D.W. Lack of mitochondrial nitric oxide production in the mouse brain. J. Neurochem. 2004, 90, 942-951.
46. Aguirre, E.; Lopez-Bernardo, E.; Cadenas, S. Functional evidence for nitric oxide production by skeletal-muscle mitochondria from lipopolysaccharide-treated mice. Mitochondrion 2012, 12, 126-131.
47. Finocchietto, P.; Barreyro, F.; Holod, S.; Peralta, J.; Franco, M.C.; Mendez, C.; Converso, D.P.; Estevez, A.; Carreras, M.C.; Poderoso, J.J. Control of muscle mitochondria by insulin entails activation of akt2-mtnos pathway: Implications for the metabolic syndrome. PLoS One 2008, 3, e1749.
48. Finocchietto, P.V.; Franco, M.C.; Holod, S.; Gonzalez, A.S.; Converso, D.P.; Antico Arciuch, V.G.; Serra, M.P.; Poderoso, J.J.; Carreras, M.C. Mitochondrial nitric oxide synthase: A masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp. Biol. Med. 2009, 234, 1020-1028.
49. Alvarez, S.; Boveris, A. Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia. Free Radic. Biol. Med. 2004, 37, 1472-1478.
50. Hussain, S.N.; El-Dwairi, Q.; Abdul-Hussain, M.N.; Sakkal, D. Expression of nitric oxide synthase isoforms in normal ventilatory and limb muscles. J. Appl. Physiol. 1997, 83, 348-353.
51. Silvagno, F.; Xia, H.; Bredt, D.S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 1996, 271, 11204-11208.
52. Grozdanovic, Z. No message from muscle. Microsc. Res. Tech. 2001, 55, 148-153.
53. Planitzer, G.; Baum, O.; Gossrau, R. Skeletal muscle fibres show nadph diaphorase activity associated with mitochondria, the sarcoplasmic reticulum and the nos-1-containing sarcolemma. Histochem. J. 2000, 32, 303-312.
54. Frandsen, U.; Lopez-Figueroa, M.; Hellsten, Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem. Biophys. Res. Commun. 1996, 227, 88-93.
55. Thomas, G.D.; Shaul, P.W.; Yuhanna, I.S.; Froehner, S.C.; Adams, M.E. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal nitric oxide synthase. Circ. Res. 2003, 92, 554-560.
56. Percival, J.M.; Anderson, K.N.; Huang, P.; Adams, M.E.; Froehner, S.C. Golgi and sarcolemmal neuronal nos differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J. Clin. Invest. 2010, 120, 816-826.
57. Ullrich, V.; Kissner, R. Redox signaling: Bioinorganic chemistry at its best. J. Inorg. Biochem. 2006, 100, 2079-2086.
58. Wang, Y.; Newton, D.C.; Miller, T.L.; Teichert, A.M.; Phillips, M.J.; Davidoff, M.S.; Marsden, P.A. An alternative promoter of the human neuronal nitric oxide synthase gene is expressed specifically in leydig cells. Am. J. Pathol. 2002, 160, 369-380.
59. Brenman, J.E.; Chao, D.S.; Xia, H.; Aldape, K.; Bredt, D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in duchenne muscular dystrophy. Cell 1995, 82, 743-752.
60. Shaul, P.W.; Smart, E.J.; Robinson, L.J.; German, Z.; Yuhanna, I.S.; Ying, Y.; Anderson, R.G.; Michel, T. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996, 271, 6518-6522.
61. Liu, J.; Garcia-Cardena, G.; Sessa, W.C. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: Mutagenesis of palmitoylation sites, cysteines-15 and/or-26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry 1995, 34, 12333-12340.
62. Belhassen, L.; Feron, O.; Kaye, D.M.; Michel, T.; Kelly, R.A. Regulation by camp of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. J. Biol. Chem. 1997, 272, 11198-11204.
63. Garcia-Cardena, G.; Martasek, P.; Masters, B.S.; Skidd, P.M.; Couet, J.; Li, S.; Lisanti, M.P.; Sessa, W.C. Dissecting the interaction between nitric oxide synthase (nos) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 1997, 272, 25437-25440.
64. Jaffrey, S.R.; Snyder, S.H. Pin: An associated protein inhibitor of neuronal nitric oxide synthase. Science 1996, 274, 774-777.
65. Fan, J.S.; Zhang, Q.; Li, M.; Tochio, H.; Yamazaki, T.; Shimizu, M.; Zhang, M. Protein inhibitor of neuronal nitric-oxide synthase, pin, binds to a 17-amino acid residue fragment of the enzyme. J. Biol. Chem. 1998, 273, 33472-33481.
66. Hemmens, B.; Woschitz, S.; Pitters, E.; Klosch, B.; Volker, C.; Schmidt, K.; Mayer, B. The protein inhibitor of neuronal nitric oxide synthase (pin): Characterization of its action on pure nitric oxide synthases. FEBS Lett. 1998, 430, 397-400.
67. Garcia-Cardena, G.; Fan, R.; Shah, V.; Sorrentino, R.; Cirino, G.; Papapetropoulos, A.; Sessa, W.C. Dynamic activation of endothelial nitric oxide synthase by hsp90. Nature 1998, 392, 821-824.
68. Ratovitski, E.A.; Alam, M.R.; Quick, R.A.; McMillan, A.; Bao, C.; Kozlovsky, C.; Hand, T.A.; Johnson, R.C.; Mains, R.E.; Eipper, B.A.; et al. Kalirin inhibition of inducible nitric-oxide synthase. J. Biol. Chem. 1999, 274, 993-999.
69. Li, H.; Poulos, T.L. Structure-function studies on nitric oxide synthases. J. Inorg. Biochem. 2005, 99, 293-305.
70. Boo, Y.C.; Kim, H.J.; Song, H.; Fulton, D.; Sessa, W.; Jo, H. Coordinated regulation of endothelial nitric oxide synthase activity by phosphorylation and subcellular localization. Free Radic. Biol. Med. 2006, 41, 144-153.
71. Song, T.; Hatano, N.; Kume, K.; Sugimoto, K.; Yamaguchi, F.; Tokuda, M.; Watanabe, Y. Inhibition of neuronal nitric-oxide synthase by phosphorylation at threonine1296 in ng108-15 neuronal cells. FEBS Lett. 2005, 579, 5658-5662.
72. Komeima, K.; Hayashi, Y.; Naito, Y.; Watanabe, Y. Inhibition of neuronal nitric-oxide synthase by calcium/calmodulin-dependent protein kinase iialpha through ser847 phosphorylation in ng108-15 neuronal cells. J. Biol. Chem. 2000, 275, 28139-28143.
73. Corson, M.A.; James, N.L.; Latta, S.E.; Nerem, R.M.; Berk, B.C.; Harrison, D.G. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 1996, 79, 984-991.
74. Maron, B.A.; Michel, T. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ. J. 2012, 76, 2497-2512.
75. Chen, C.A.; Wang, T.Y.; Varadharaj, S.; Reyes, L.A.; Hemann, C.; Talukder, M.A.; Chen, Y.R.; Druhan, L.J.; Zweier, J.L. S-glutathionylation uncouples enos and regulates its cellular and vascular function. Nature 2010, 468, 1115-1118.
76. Zweier, J.L.; Chen, C.A.; Druhan, L.J. S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid. Redox Signal. 2011, 14, 1769-1775.
77. Erwin, P.A.; Lin, A.J.; Golan, D.E.; Michel, T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 2005, 280, 19888-19894.
78. Erwin, P.A.; Mitchell, D.A.; Sartoretto, J.; Marletta, M.A.; Michel, T. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J. Biol. Chem. 2006, 281, 151-157.
79. Jin, B.Y.; Sartoretto, J.L.; Gladyshev, V.N.; Michel, T. Endothelial nitric oxide synthase negatively regulates hydrogen peroxide-stimulated amp-activated protein kinase in endothelial cells. Proc. Natl. Acad. Sci. USA 2009, 106, 17343-17348.
80. Sartoretto, J.L.; Kalwa, H.; Pluth, M.D.; Lippard, S.J.; Michel, T. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc. Natl. Acad. Sci. USA 2011, 108, 15792-15797.
81. Waypa, G.B.; Marks, J.D.; Guzy, R.; Mungai, P.T.; Schriewer, J.; Dokic, D.; Schumacker, P.T. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ. Res. 2010, 106, 526-535.
82. Moncada, S.; Erusalimsky, J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 2002, 3, 214-220.
83. Reid, M.B. Role of nitric oxide in skeletal muscle: Synthesis, distribution and functional importance. Acta Physiol. Scand. 1998, 162, 401-409.
84. Stamler, J.S.; Singel, D.J.; Loscalzo, J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992, 258, 1898-1902.
85. Kobzik, L.; Reid, M.B.; Bredt, D.S.; Stamler, J.S. Nitric oxide in skeletal muscle. Nature 1994, 372, 546-548.
86. Stamler, J.S. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 1994, 78, 931-936.
87. Wolzt, M.; MacAllister, R.J.; Davis, D.; Feelisch, M.; Moncada, S.; Vallance, P.; Hobbs, A.J. Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity. J. Biol. Chem. 1999, 274, 28983-28990.
88. Nisoli, E.; Carruba, M.O. Nitric oxide and mitochondrial biogenesis. J. Cell Sci. 2006, 119, 2855-2862.
89. Chance, B.; Williams, G.R. Respiratory enzymes in oxidative phosphorylation. J. Biol. Chem. 1955, 217, 383-427.
90. Cadenas, E. Mitochondrial free radical production and cell signaling. Mol. Asp. Med. 2004, 25, 17-26.
91. Cleeter, M.W.; Cooper, J.M.; Darley-Usmar, V.M.; Moncada, S.; Schapira, A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994, 345, 50-54.
92. Brown, G.C.; Cooper, C.E. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994, 356, 295-298.
93. Giulivi, C. Characterization and function of mitochondrial nitric-oxide synthase. Free Radic. Biol. Med. 2003, 34, 397-408.
94. Taylor, C.T.; Moncada, S. Nitric oxide, cytochrome c oxidase, and the cellular response to hypoxia. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 643-647.
95. Poderoso, J.J.; Carreras, M.C.; Lisdero, C.; Riobo, N.; Schopfer, F.; Boveris, A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 1996, 328, 85-92.
96. Clementi, E.; Brown, G.C.; Feelisch, M.; Moncada, S. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex i and protective action of glutathione. Proc. Natl Acad. Sci. USA 1998, 95, 7631-7636.
97. Brown, G.C.; Borutaite, V. Inhibition of mitochondrial respiratory complex i by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 2004, 1658, 44-49.
98. Beltran, B.; Orsi, A.; Clementi, E.; Moncada, S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 2000, 129, 953-960.
99. Riobo, N.A.; Clementi, E.; Melani, M.; Boveris, A.; Cadenas, E.; Moncada, S.; Poderoso, J.J. Nitric oxide inhibits mitochondrial nadh:Ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 2001, 359, 139-145.
100. Murray, J.; Taylor, S.W.; Zhang, B.; Ghosh, S.S.; Capaldi, R.A. Oxidative damage to mitochondrial complex i due to peroxynitrite: Identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 2003, 278, 37223-37230.
101. Pearce, L.L.; Kanai, A.J.; Epperly, M.W.; Peterson, J. Nitrosative stress results in irreversible inhibition of purified mitochondrial complexes i and iii without modification of cofactors. Nitric Oxide 2005, 13, 254-263.
102. Pearce, L.L.; Martinez-Bosch, S.; Manzano, E.L.; Winnica, D.E.; Epperly, M.W.; Peterson, J. The resistance of electron-transport chain fe-s clusters to oxidative damage during the reaction of peroxynitrite with mitochondrial complex ii and rat-heart pericardium. Nitric Oxide 2009, 20, 135-142.
103. McConell, G.K.; Phillips, M.; Ruan, Z.; Macaulay, S.L.; Wadley, G.D. Central role of nitric oxide synthase in aicar and caffeine-induced mitochondrial biogenesis in l6 myocytes. J. Appl. Physiol. 2010, 108, 589-595.
104. Nisoli, E.; Falcone, S.; Tonello, C.; Cozzi, V.; Palomba, L.; Fiorani, M.; Pisconti, A.; Brunelli, S.; Cardile, A.; Francolini, M.; et al. Mitochondrial biogenesis by no yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA 2004, 101, 16507-16512.
105. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R.C.; et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator pgc-1. Cell 1999, 98, 115-124.
106. Braidotti, G.; Borthwick, I.A.; May, B.K. Identification of regulatory sequences in the gene for 5-aminolevulinate synthase from rat. J. Biol. Chem. 1993, 268, 1109-1117.
107. Scarpulla, R.C. Nuclear control of respiratory chain expression in mammalian cells. J. Bioenerg. Biomembr. 1997, 29, 109-119.
108. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R.; Zeiher, A.M. Activation of nitric oxide synthase in endothelial cells by akt-dependent phosphorylation. Nature 1999, 399, 601-605.
109. Wu, Z.; Huang, X.; Feng, Y.; Handschin, C.; Feng, Y.; Gullicksen, P.S.; Bare, O.; Labow, M.; Spiegelman, B.; Stevenson, S.C. Transducer of regulated creb-binding proteins (torcs) induce pgc-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc. Natl. Acad. Sci. USA 2006, 103, 14379-14384.
110. Bellis, A.; Castaldo, D.; Trimarco, V.; Monti, M.G.; Chivasso, P.; Sadoshima, J.; Trimarco, B.; Morisco, C. Cross-talk between pka and akt protects endothelial cells from apoptosis in the late ischemic preconditioning. Arterioscler. Thrombosis Vasc. Biol. 2009, 29, 1207-1212.
111. Piantadosi, C.A.; Suliman, H.B. Mitochondrial transcription factor a induction by redox activation of nuclear respiratory factor 1. J. Biol. Chem. 2006, 281, 324-333.
112. Piantadosi, C.A.; Suliman, H.B. Redox regulation of mitochondrial biogenesis. Free Radic. Biol. Med. 2012, 53, 2043-2053.
113. Steinberg, G.R.; Kemp, B.E. Ampk in health and disease. Physiol. Rev. 2009, 89, 1025-1078.
114. Bergeron, R.; Ren, J.M.; Cadman, K.S.; Moore, I.K.; Perret, P.; Pypaert, M.; Young, L.H.; Semenkovich, C.F.; Shulman, G.I. Chronic activation of amp kinase results in nrf-1 activation and mitochondrial biogenesis. Am. J. Phys. Endocrinol. Metab. 2001, 281, E1340-E1346.
115. Zong, H.; Ren, J.M.; Young, L.H.; Pypaert, M.; Mu, J.; Birnbaum, M.J.; Shulman, G.I. Amp kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 2002, 99, 15983-15987.
116. Reznick, R.M.; Shulman, G.I. The role of amp-activated protein kinase in mitochondrial biogenesis. J. Physiol. 2006, 574, 33-39.
117. Gollnick, P.D.; King, D.W. Effect of exercise and training on mitochondria of rat skeletal muscle. Am. J. Phys. 1969, 216, 1502-1509.
118. Hoppeler, H.; Luthi, P.; Claassen, H.; Weibel, E.R.; Howald, H. The ultrastructure of the normal human skeletal muscle. A morphometric analysis on untrained men, women and well-trained orienteers. Pflugers Arch. 1973, 344, 217-232.
119. Holloszy, J.O.; Booth, F.W. Biochemical adaptations to endurance exercise in muscle. Ann. Rev. Physiol. 1976, 38, 273-291.
120. Balon, T.W.; Nadler, J.L. Nitric oxide release is present from incubated skeletal muscle preparations. J. Appl. Physiol.1994, 77, 2519-2521.
121. Roberts, C.K.; Barnard, R.J.; Jasman, A.; Balon, T.W. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am. J. Physiol. 1999, 277, E390-E394.
122. Ojuka, E.O.; Jones, T.E.; Han, D.H.; Chen, M.; Wamhoff, B.R.; Sturek, M.; Holloszy, J.O. Intermittent increases in cytosolic Ca2+ stimulate mitochondrial biogenesis in muscle cells. Am. J. Physiol. Endocrinol. Metab. 2002, 283, E1040-E1045.
123. Wu, H.; Kanatous, S.B.; Thurmond, F.A.; Gallardo, T.; Isotani, E.; Bassel-Duby, R.; Williams, R.S. Regulation of mitochondrial biogenesis in skeletal muscle by camk. Science 2002, 296, 349-352.
124. Chen, Z.P.; Stephens, T.J.; Murthy, S.; Canny, B.J.; Hargreaves, M.; Witters, L.A.; Kemp, B.E.; McConell, G.K. Effect of exercise intensity on skeletal muscle ampk signaling in humans. Diabetes 2003, 52, 2205-2212.
125. Chen, Z.P.; McConell, G.K.; Michell, B.J.; Snow, R.J.; Canny, B.J.; Kemp, B.E. Ampk signaling in contracting human skeletal muscle: Acetyl-coa carboxylase and no synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 2000, 279, E1202-E1206.
126. Godinho, R.O. In vitro development of skeletal muscle fiber. Braz. J. Morphol. Sci. 2006, 23, 173-186.
127. Lee, K.H.; Baek, M.Y.; Moon, K.Y.; Song, W.K.; Chung, C.H.; Ha, D.B.; Kang, M.S. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 1994, 269, 14371-14374.
128. De Palma, C.; Falcone, S.; Pisoni, S.; Cipolat, S.; Panzeri, C.; Pambianco, S.; Pisconti, A.; Allevi, R.; Bassi, M.T.; Cossu, G.; et al. Nitric oxide inhibition of drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ. 2010, 17, 1684-1696.
129. Okamoto, K.; Shaw, J.M. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Ann. Rev. Genet. 2005, 39, 503-536.
130. Suen, D.F.; Norris, K.L.; Youle, R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008, 22, 1577-1590.
131. Hoppins, S.; Lackner, L.; Nunnari, J. The machines that divide and fuse mitochondria. Ann. Rev. Biochem. 2007, 76, 751-780.
132. Levine, A.B.; Punihaole, D.; Levine, T.B. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012, 122, 55-68.
133. Civitarese, A.E.; Carling, S.; Heilbronn, L.K.; Hulver, M.H.; Ukropcova, B.; Deutsch, W.A.; Smith, S.R.; Ravussin, E. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007, 4, e76.
134. Cerqueira, F.M.; Laurindo, F.R.; Kowaltowski, A.J. Mild mitochondrial uncoupling and calorie restriction increase fasting enos, akt and mitochondrial biogenesis. PLoS One 2011, 6, e18433.
135. Wadley, G.D.; Choate, J.; McConell, G.K. Nos isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle. J. Physiol. 2007, 585, 253-262.
136. Lira, V.A.; Benton, C.R.; Yan, Z.; Bonen, A. Pgc-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E145-E161.
137. Lee-Young, R.S.; Ayala, J.E.; Hunley, C.F.; James, F.D.; Bracy, D.P.; Kang, L.; Wasserman, D.H. Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298, R1399-R1408.
138. Adhihetty, P.J.; Taivassalo, T.; Haller, R.G.; Walkinshaw, D.R.; Hood, D.A. The effect of training on the expression of mitochondrial biogenesis-and apoptosis-related proteins in skeletal muscle of patients with mtdna defects. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E672-E680.
139. Taivassalo, T.; Haller, R.G. Exercise and training in mitochondrial myopathies. Med. Sci. Sports Exercise 2005, 37, 2094-2101.
140. Murphy, J.L.; Blakely, E.L.; Schaefer, A.M.; He, L.; Wyrick, P.; Haller, R.G.; Taylor, R.W.; Turnbull, D.M.; Taivassalo, T. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 2008, 131, 2832-2840.
141. El-Hattab, A.W.; Emrick, L.T.; Craigen, W.J.; Scaglia, F. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol. Genet. Metab. 2012, 107, 247-252.
142. Koga, Y.; Akita, Y.; Nishioka, J.; Yatsuga, S.; Povalko, N.; Tanabe, Y.; Fujimoto, S.; Matsuishi, T. L-arginine improves the symptoms of strokelike episodes in melas. Neurology 2005, 64, 710-712.
143. Koga, Y.; Ishibashi, M.; Ueki, I.; Yatsuga, S.; Fukiyama, R.; Akita, Y.; Matsuishi, T. Effects of L-arginine on the acute phase of strokes in three patients with melas. Neurology 2002, 58, 827-828.
144. Naini, A.; Kaufmann, P.; Shanske, S.; Engelstad, K.; de Vivo, D.C.; Schon, E.A. Hypocitrullinemia in patients with melas: An insight into the "melas paradox". J. Neurol. Sci. 2005, 229-230, 187-193.
145. Koga, Y.; Akita, Y.; Junko, N.; Yatsuga, S.; Povalko, N.; Fukiyama, R.; Ishii, M.; Matsuishi, T. Endothelial dysfunction in melas improved by L-arginine supplementation. Neurology 2006, 66, 1766-1769.
146. Koga, Y.; Akita, Y.; Nishioka, J.; Yatsuga, S.; Povalko, N.; Katayama, K.; Matsuishi, T. Melas and L-arginine therapy. Mitochondrion 2007, 7, 133-139.
147. El-Hattab, A.W.; Hsu, J.W.; Emrick, L.T.; Wong, L.J.; Craigen, W.J.; Jahoor, F.; Scaglia, F. Restoration of impaired nitric oxide production in melas syndrome with citrulline and arginine supplementation. Mol. Genet. Metab. 2012, 105, 607-614.
148. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and pgc-1alpha. Cell 2006, 127, 1109-1122.
149. Zheng, J.; Chen, L.L.; Zhang, H.H.; Hu, X.; Kong, W.; Hu, D. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle. Metabolism 2012, 61, 954-965.
150. Price, N.L.; Gomes, A.P.; Ling, A.J.; Duarte, F.V.; Martin-Montalvo, A.; North, B.J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J.S.; et al. Sirt1 is required for ampk activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012, 15, 675-690.
151. Csiszar, A.; Labinskyy, N.; Pinto, J.T.; Ballabh, P.; Zhang, H.; Losonczy, G.; Pearson, K.; de Cabo, R.; Pacher, P.; Zhang, C.; et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 297, H13-H20.
152. Zhou, Q.; Liao, J.K. Pleiotropic effects of statins-Basic research and clinical perspectives. Circ. J. 2010, 74, 818-826.
153. D'Antona, G.; Mascaro, A.; Monopoli, A.; Miglietta, D.; Ongini, E.; Bottinelli, R. Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice. Muscle Nerve 2012, doi:10.1002/mus.23465.
154. Brunelli, S.; Sciorati, C.; D'Antona, G.; Innocenzi, A.; Covarello, D.; Galvez, B.G.; Perrotta, C.; Monopoli, A.; Sanvito, F.; Bottinelli, R.; et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl. Acad. Sci. USA 2007, 104, 264-269.
155. Archer, J.D.; Vargas, C.C.; Anderson, J.E. Persistent and improved functional gain in mdx dystrophic mice after treatment with l-arginine and deflazacort. FASEB J. 2006, 20, 738-740.
156. Buono, R.; Vantaggiato, C.; Pisa, V.; Azzoni, E.; Bassi, M.T.; Brunelli, S.; Sciorati, C.; Clementi, E. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring vangl2 and cyclic gmp. Stem Cells 2012, 30, 197-209.